financetom
Business
financetom
/
Business
/
Update: Foran Mining Says McIlvenna Bay Project in Saskatchewan 50% Complete
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Foran Mining Says McIlvenna Bay Project in Saskatchewan 50% Complete
Aug 26, 2025 9:11 AM

11:48 AM EDT, 08/26/2025 (MT Newswires) -- (Adds investment bank comment and updates shares.)

Foran Mining ( FMCXF ) said Tuesday that construction progress of the McIlvenna Bay project in Saskatchewan is 50% complete.

The project remains on budget and schedule, with commercial production targeted for mid-2026, Foran said.

Foran said key construction milestones in July include ball mill lining completion, significant progress with structural steel and concrete works and installation of floatation cells.

The company also advanced about 570 meters of underground development in July.

"Surpassing the halfway point of construction is an incredible milestone, and I am extremely proud of the relentless determination and operational excellence shown by our team," said executive chair Dan Myerson.

"Our focus remains on disciplined execution and long-term value creation, supported by consistent, transparent updates as we advance construction, and today's announcement reinforces that both schedule and budget remain firmly on track," Myerson said.

National Bank of Canada kept its outperform rating with a speculative risk rating and $4.25 price target on Foran shares after the update.

National Bank said the speculative risk rating recognizes that its thesis is contingent on execution and future growth, net government tax credits and significant exploration upside, which is already factored into our estimates.

According to National Bank, Foran has tended to trade at a premium on P/NAV versus developer peers (0.55x NAVPS average) due to its near-term development, Tier 1 jurisdiction, supportive financial backers, and expectations for future phased expansions.

Foran shares were last seen up $0.135 to $3.005 on the Toronto Stock Exchange.

Price: 3.01, Change: +0.14, Percent Change: +4.70

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cleanspark Fiscal Q1 Swings to Loss, Revenue Rises
Cleanspark Fiscal Q1 Swings to Loss, Revenue Rises
Mar 11, 2026
05:43 PM EST, 02/05/2026 (MT Newswires) -- Cleanspark ( CLSK ) reported a fiscal Q1 loss of $1.35 per diluted share, swinging from earnings of $0.83 a year earlier. Analysts polled by FactSet expected a loss of $0.31. Revenue for the three months ended Dec. 31 was $181.2 million, up from $162.3 million a year earlier. Analysts surveyed by FactSet...
Qualys Fiscal Q4 Adjusted Earnings, Revenue Rise; Sets Q1, 2026 Guidance
Qualys Fiscal Q4 Adjusted Earnings, Revenue Rise; Sets Q1, 2026 Guidance
Mar 11, 2026
05:15 PM EST, 02/05/2026 (MT Newswires) -- Qualys ( QLYS ) reported fiscal Q4 adjusted net income late Thursday of $1.87 per diluted share, up from $1.60 a year earlier. Analysts polled by FactSet expected $1.78. Revenue for the three months ended Dec. 31 rose to $175.3 million from $159.2 million a year earlier. Analysts polled by FactSet expected $173.2...
Hub Group Preliminary Fiscal 2026 Revenue; Sets 2026 Guidance; Delays Earnings Release
Hub Group Preliminary Fiscal 2026 Revenue; Sets 2026 Guidance; Delays Earnings Release
Mar 11, 2026
05:43 PM EST, 02/05/2026 (MT Newswires) -- Hub Group ( HUBG ) said Thursday its fiscal year 2025 preliminary revenue is expected to come in between $3.65 billion and $3.95 billion, compared to $3.95 billion a year earlier. Analysts polled by FactSet expected $3.67 billion. For the full year 2026, the company estimates revenue between $3.65 billion and $3.95 billion....
Adaptive Biotechnologies Q4 Loss Narrows, Revenue Climbs
Adaptive Biotechnologies Q4 Loss Narrows, Revenue Climbs
Mar 11, 2026
05:44 PM EST, 02/05/2026 (MT Newswires) -- Adaptive Biotechnologies ( ADPT ) reported Q4 net loss late Thursday of $0.09 per diluted share, narrowing from $0.23 a year earlier. Analysts polled by FactSet expected loss of $0.19. Revenue for the quarter ended Dec. 31 was $71.7 million, up from $47.5 million a year earlier. Analysts expected $60.9 million. As of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved